๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Enoxaparin sodium - Medicines in Ireland

38 authorised products containing Enoxaparin sodium, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 38 authorised medicines
MedicineActive substanceLicence holderStatus
Clexane 10,000 IU (100 mg)/1 ml Solution for Injection in pre-filled syringes
PPA0465/477/001
Enoxaparin sodium PCO Manufacturing Ltd. โ€”
Clexane 10,000 IU (100mg)/1ml Solution for Injection in pre-filled syringes
PA0540/097/001
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Clexane 2,000 IU (20mg)/0.2 mL Solution for Injection in pre-filled syringes
PA0540/097/004
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI โ€”
Clexane 4,000 IU (40 mg) /0.4 ml Solution for Injection in pre-filled syringes
PPA0465/477/002
Enoxaparin sodium PCO Manufacturing Ltd. โ€”
Clexane 4,000 IU (40mg)/0.4 mL Solution for Injection in pre-filled syringes
PA0540/097/005
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI โ€”
Clexane 6,000 IU (60 mg) /0.6 ml Solution for Injection in pre-filled syringes
PPA0465/477/003
Enoxaparin sodium PCO Manufacturing Ltd. โ€”
Clexane 6,000 IU (60mg)/0.6 mL Solution for Injection in pre-filled syringes
PA0540/097/006
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI โ€”
Clexane 8,000 IU (80 mg) /0.8 ml Solution for Injection in pre-filled syringes
PPA0465/477/004
Enoxaparin sodium PCO Manufacturing Ltd. โ€”
Clexane 8,000 IU (80mg)/0.8 mL Solution for Injection in pre-filled syringes
PA0540/097/007
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI โ€”
Clexane Forte 12,000 IU (120 mg)/0.8 ml Solution for Injection in pre-filled syringes
PPA0465/477/005
Enoxaparin sodium PCO Manufacturing Ltd. โ€”
Clexane Forte 12,000 IU (120mg)/0.8 mL Solution for Injection in pre-filled syringes
PA0540/097/008
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI โ€”
Clexane Forte 15,000 IU (150mg)/1ml Solution for Injection in pre-filled syringes
PA0540/097/002
Enoxaparin sodium Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Enoxaparin sodium Ledraxen 10,000 IU (100 mg)/1 mL, solution for injection in pre-filled syringe
PA23258/001/001
Enoxaparin sodium Venipharm Not marketed
Enoxaparin sodium Ledraxen 2,000 IU (20 mg)/0.2 mL, solution for injection in pre-filled syringe
PA23258/001/005
Enoxaparin sodium Venipharm Not marketed
Enoxaparin sodium Ledraxen 4,000 IU (40 mg)/0.4 mL, solution for injection in pre-filled syringe
PA23258/001/004
Enoxaparin sodium Venipharm Not marketed
Enoxaparin sodium Ledraxen 6,000 IU (60 mg)/0.6 mL, solution for injection in pre-filled syringe
PA23258/001/003
Enoxaparin sodium Venipharm Not marketed
Enoxaparin sodium Ledraxen 8,000 IU (80 mg)/0.8 mL, solution for injection in pre-filled syringe
PA23258/001/002
Enoxaparin sodium Venipharm Not marketed
Ghemaxan 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringes
PA22937/001/005
Enoxaparin sodium Chemi S.p.A. Not marketed
Ghemaxan 12,000 IU (120 mg)/0.8 mL solution for injection in pre-filled syringes
PA22937/001/006
Enoxaparin sodium Chemi S.p.A. Not marketed
Ghemaxan 15,000 IU (150 mg)/1 mL solution for injection in pre-filled syringes
PA22937/001/007
Enoxaparin sodium Chemi S.p.A. Not marketed
Ghemaxan 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringes
PA22937/001/001
Enoxaparin sodium Chemi S.p.A. Not marketed
Ghemaxan 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringes
PA22937/001/002
Enoxaparin sodium Chemi S.p.A. Not marketed
Ghemaxan 6,000 IU (60 mg)/0.6 mL solution for injection in pre-filled syringes
PA22937/001/003
Enoxaparin sodium Chemi S.p.A. Not marketed
Ghemaxan 8,000 IU (80 mg)/0.8 mL solution for injection in pre-filled syringes
PA22937/001/004
Enoxaparin sodium Chemi S.p.A. Not marketed
Inhixa 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringe
EU/1/16/1132/009-010
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 12,000 IU (120 mg)/0.8 mL solution for injection in pre-filled syringe
EU/1/16/1132/069
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 15,000 IU (150 mg)/1 mL solution for injection in pre-filled syringe
EU/1/16/1132/070
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringe
EU/1/16/1132/001-002
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 30,000 IU (300 mg)/3 mL solution for injection in multidose container
EU/1/16/1132/071
Enoxaparin sodium, Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringe
EU/1/16/1132/003-004
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 50,000 IU (500 mg)/5 mL solution for injection in multidose container
EU/1/16/1132/072
Enoxaparin sodium, Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 6,000 IU (60 mg)/0.6 mL solution for injection in pre-filled syringe
EU/1/16/1132/005-006
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Inhixa 8,000 IU (80 mg)/0.8 mL solution for injection in pre-filled syringe
EU/1/16/1132/007-008
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Thorinane
EU/1/16/1131/001-002
Enoxaparin sodium Techdow Pharma Netherlands B.V โ€”
Thorinane
EU/1/16/1131/003-004
Enoxaparin sodium Pharmathen S.A. โ€”
Thorinane
EU/1/16/1131/005-006
Enoxaparin sodium Pharmathen S.A. โ€”
Thorinane
EU/1/16/1131/007-008
Enoxaparin sodium Pharmathen S.A. โ€”
Thorinane
EU/1/16/1131/009-010
Enoxaparin sodium Pharmathen S.A. โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.